Cellectis S.A. Files Routine 6-K Report

Ticker: CLLS · Form: 6-K · Filed: Jul 28, 2025 · CIK: 1627281

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer

TL;DR

Cellectis S.A. filed a standard 6-K, no major news.

AI Summary

Cellectis S.A. filed a Form 6-K on July 28, 2025, reporting as a foreign private issuer. The company, based in Paris, France, is involved in the biological products sector. This filing is routine and does not contain specific financial or operational updates beyond its classification and reporting status.

Why It Matters

This filing confirms Cellectis S.A.'s status as a foreign private issuer and its adherence to SEC reporting requirements, which is important for investors tracking the company's regulatory compliance.

Risk Assessment

Risk Level: low — This is a routine administrative filing (Form 6-K) that does not contain new material financial or operational information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information that the company makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.

What is Cellectis S.A.'s primary business sector?

Cellectis S.A. is in the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) sector, SIC code [2836].

Where is Cellectis S.A. headquartered?

Cellectis S.A.'s principal executive office is located at 8, rue de la Croix Jarry, 75013 Paris, France.

Does this filing indicate Cellectis S.A. is submitting its annual report?

The filing indicates that Cellectis S.A. files annual reports under cover of Form 20-F, but this specific 6-K filing is not stated to be an annual report itself.

What is the Commission File Number for Cellectis S.A.?

The Commission File Number for Cellectis S.A. is 001-36891.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on July 28, 2025 regarding Cellectis S.A. (CLLS).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing